Somatostatin-dopamine chimeric analogs

The present invention relates to novel somatostatin-dopamine chimeric analogs and their therapeutic uses for the inhibition, prevention, and/or treatment of neoplasia, neuroendocrine tumors, Cushing's disease/syndrome, and other conditions.

Saved in:
Bibliographic Details
Main Authors Dong Zheng Xin, Shen Yeelana, Kim Sun Hyuk
Format Patent
LanguageEnglish
Published 15.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel somatostatin-dopamine chimeric analogs and their therapeutic uses for the inhibition, prevention, and/or treatment of neoplasia, neuroendocrine tumors, Cushing's disease/syndrome, and other conditions.
Bibliography:Application Number: US201314439162